Diverse, high-quality test set for the validation of protein-ligand docking performance

被引:500
作者
Hartshorn, Michael J. [1 ]
Verdonk, Marcel L. [1 ]
Chessari, Gianni [1 ]
Brewerton, Suzanne C. [1 ]
Mooij, Wijnand T. M. [1 ]
Mortenson, Paul N. [1 ]
Murray, Christopher W. [1 ]
机构
[1] Astex Therapeut Ltd, Cambridge CB4 0QA, England
关键词
D O I
10.1021/jm061277y
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A procedure for analyzing and classifying publicly available crystal structures has been developed. It has been used to identify high-resolution protein-ligand complexes that can be assessed by reconstructing the electron density for the ligand using the deposited structure factors. The complexes have been clustered according to the protein sequences, and clusters have been discarded if they do not represent proteins thought to be of direct interest to the pharmaceutical or agrochemical industry. Rules have been used to exclude complexes containing non-drug-like ligands. One complex from each cluster has been selected where a structure of sufficient quality was available. The final Astex diverse set contains 85 diverse, relevant protein-ligand complexes, which have been prepared in a format suitable for docking and are to be made freely available to the entire research community (http://www.ccdc.cam.ac.uk). The performance of the docking program GOLD against the new set is assessed using a variety of protocols. Relatively unbiased protocols give success rates of approximately 80% for redocking into native structures, but it is possible to get success rates of over 90% with some protocols.
引用
收藏
页码:726 / 741
页数:16
相关论文
共 137 条
[61]   Structure based design of 4-(3-aminomethylphenyl)piperidinyl-1-amides:: novel, potent, selective, and orally bioavailable inhibitors of βII tryptase [J].
Levell, J ;
Astles, P ;
Eastwood, P ;
Cairns, J ;
Houille, O ;
Aldous, S ;
Merriman, G ;
Whiteley, B ;
Pribish, J ;
Czekaj, M ;
Liang, GY ;
Maignan, S ;
Guilloteau, JP ;
Dupuy, A ;
Davidson, J ;
Harrison, T ;
Morley, A ;
Watson, S ;
Fenton, G ;
McCarthy, C ;
Romano, J ;
Mathew, R ;
Engers, D ;
Gardyan, M ;
Sides, K ;
Kwong, J ;
Tsay, J ;
Rebello, S ;
Shen, LD ;
Wang, J ;
Luo, YY ;
Giardino, O ;
Lim, HK ;
Smith, K ;
Pauls, H .
BIOORGANIC & MEDICINAL CHEMISTRY, 2005, 13 (08) :2859-2872
[62]   Is the critical role of loop 3 of Escherichia coli 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase in catalysis due to loop-3 residues arginine-84 and tryptophan-89?: Site-directed mutagenesis, biochemical, and crystallographic studies [J].
Li, Y ;
Blaszczyk, J ;
Wu, Y ;
Shi, GB ;
Ji, XH ;
Yan, HG .
BIOCHEMISTRY, 2005, 44 (24) :8590-8599
[63]   Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings [J].
Lipinski, CA ;
Lombardo, F ;
Dominy, BW ;
Feeney, PJ .
ADVANCED DRUG DELIVERY REVIEWS, 1997, 23 (1-3) :3-25
[64]   A benzoic acid inhibitor induces a novel conformational change in the active site of Influenza B virus neurarninidase [J].
Lommer, BS ;
Ali, SM ;
Bajpai, SN ;
Brouillette, WJ ;
Air, GM ;
Luo, M .
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2004, 60 :1017-1023
[65]   Calf spleen purine-nucleoside phosphorylase: crystal structure of the binary complex with a potent multisubstrate analogue inhibitor [J].
Luic, M ;
Koellner, G ;
Yokomatsu, T ;
Shibuya, S ;
Bzowska, A .
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2004, 60 :1417-1424
[66]   Progesterone receptor ligand binding pocket flexibility: Crystal structures of the norethindrone and mometasone furoate complexes [J].
Madauss, KP ;
Deng, SJ ;
Austin, RJH ;
Lambert, MH ;
McLay, I ;
Pritchard, J ;
Short, SA ;
Stewart, EL ;
Uings, IJ ;
Williams, SP .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (13) :3381-3387
[67]   Imatinib: a selective tyrosine kinase inhibitor [J].
Manley, PW ;
Cowan-Jacob, SW ;
Buchdunger, E ;
Fabbro, D ;
Fendrich, G ;
Furet, P ;
Meyer, T ;
Zimmermann, J .
EUROPEAN JOURNAL OF CANCER, 2002, 38 :S19-S27
[68]   Mechanism of CDK5/p25 binding by CDK inhibitors [J].
Mapelli, M ;
Massimiliano, L ;
Crovace, C ;
Seeliger, MA ;
Tsai, LH ;
Meijer, L ;
Musacchio, A .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (03) :671-679
[69]   Getting the adrenaline going: Crystal structure of the adrenaline-synthesizing enzyme PNMT [J].
Martin, JL ;
Begun, J ;
McLeish, MJ ;
Caine, JM ;
Grunewald, GL .
STRUCTURE, 2001, 9 (10) :977-985
[70]   Design and quantitative structure-activity relationship of 3-amidinobenzyl-1H-indole-2-carboxamides as potent, nonchiral, and selective inhibitors of blood coagulation factor Xa [J].
Matter, H ;
Defossa, E ;
Heinelt, U ;
Blohm, PM ;
Schneider, D ;
Müller, A ;
Herok, S ;
Schreuder, H ;
Liesum, A ;
Brachvogel, V ;
Lönze, P ;
Walser, A ;
Al-Obeidi, F ;
Wildgoose, P .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (13) :2749-2769